4.7 Article

Microglia Contributes to BAF-312 Effects on Blood-Brain Barrier Stability

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Decreased Astrocytic CCL2 Accounts for BAF-312 Effect on PBMCs Transendothelial Migration Through a Blood Brain Barrier in Vitro Model

Simona F. Spampinato et al.

Summary: The study demonstrates that BAF-312 can reduce the migration of peripheral blood mononuclear cells through endothelial cells under inflammatory conditions by controlling astrocyte activation, adhesion molecule expression, and proinflammatory cytokines and chemokines levels, highlighting the importance of astrocytes in mediating drug effects on BBB function.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Microglial polarization differentially affects neuronal vulnerability to the β-amyloid protein: Modulation by melatonin

Sara Merlo et al.

Summary: This study explored the effects of melatonin on microglial cells in Alzheimer's disease and found that melatonin can inhibit inflammation, restore the expression of beneficial genes, and protect neuronal cells from damage caused by beta-amyloid.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of NR4A Genes in Microglia Cell Line

Francesca Montarolo et al.

Summary: Fingolimod and siponimod are drugs used for the treatment of multiple sclerosis by activating sphingosine-1-phosphate receptors. BAF312 has pro-myelination and neuro-protective effects on CNS cells, and this effect may be related to the regulation of NR4A genes.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)

Article Pharmacology & Pharmacy

Protective effect of the sphingosine-1 phosphate receptor agonist siponimod on disrupted blood brain barrier function

Simona Federica Spampinato et al.

Summary: Sphingosine 1 phosphate (S1P) is a bioactive sphingolipid with important physiological and pathological functions. The drug siponimod (BAF-312) has been approved for secondary progressive MS treatment by targeting S1P1 and S1P5 receptors, showing potential to strengthen BBB properties and provide additional effects for MS treatment.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

SIRT1-Dependent Upregulation of BDNF in Human Microglia Challenged with Aβ: An Early but Transient Response Rescued by Melatonin

Grazia Ilaria Caruso et al.

Summary: Microglia show an early defensive response to Aβ42, involving SIRT1-mediated BDNF upregulation, which can be externally modulated by melatonin. Prolonged exposure to Aβ42 leads to changes in microglial features, with increased inflammatory markers, while melatonin exhibits protective effects by preventing NF-kB nuclear translocation and acetylation.

BIOMEDICINES (2021)

Article Clinical Neurology

Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insights

Marc Bigaud et al.

Summary: The study confirms the penetration and distribution of Siponimod in the central nervous system across species, showing high translational potential to humans.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2021)

Review Neurosciences

The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention

Sara Merlo et al.

CURRENT NEUROPHARMACOLOGY (2020)

Review Neurosciences

Neurovascular Unit Dysfunction and Neurodegenerative Disorders

Xing Yu et al.

FRONTIERS IN NEUROSCIENCE (2020)

Review Endocrinology & Metabolism

Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity

Patrick T. Ronaldson et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)

Article Multidisciplinary Sciences

A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord

Sebok K. Halder et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Pharmacology & Pharmacy

Astrocyte-Derived Paracrine Signals: Relevance for Neurogenic Niche Regulation and Blood-Brain Barrier Integrity

Simona Federica Spampinato et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Clinical Neurology

Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod

F. Montarolo et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Multidisciplinary Sciences

Dual microglia effects on blood brain barrier permeability induced by systemic inflammation

Koichiro Haruwaka et al.

NATURE COMMUNICATIONS (2019)

Review Neurosciences

Different Approaches to Modulation of Microglia Phenotypes After Spinal Cord Injury

Elvira Akhmetzyanova et al.

FRONTIERS IN SYSTEMS NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

Microglial recruitment of IL-1 beta-producing monocytes to brain endothelium causes stress-induced anxiety

D. B. McKim et al.

MOLECULAR PSYCHIATRY (2018)

Review Neurosciences

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

Sara Bachiller et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Article Biochemistry & Molecular Biology

Astrocytes contribute to Aβ-induced blood-brain barrier damage through activation of endothelial MMP9

Simona Federica Spampinato et al.

JOURNAL OF NEUROCHEMISTRY (2017)

Review Neurosciences

The blood-brain barrier in Alzheimer's disease

Elena Zenaro et al.

NEUROBIOLOGY OF DISEASE (2017)

Article Biochemistry & Molecular Biology

Poly(ADP-ribose) polymerase-1 regulates microglia mediated decrease of endothelial tight junction integrity

Abbas Rezaeian Mehrabadi et al.

NEUROCHEMISTRY INTERNATIONAL (2017)

Article Biochemistry & Molecular Biology

Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm

Emilia Laudati et al.

NEUROCHEMISTRY INTERNATIONAL (2017)

Article Geriatrics & Gerontology

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease

Sudhakar R. Subramaniam et al.

FRONTIERS IN AGING NEUROSCIENCE (2017)

Review Biochemistry & Molecular Biology

Clinical pharmacology, efficacy, and safety aspects of sphingosine-1-phosphate receptor modulators

Pierre-Eric Juif et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)

Article Multidisciplinary Sciences

Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier

Nanhong Lou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Biochemistry & Molecular Biology

Sphingosine 1-phosphate signaling at the blood-brain barrier

Briana Prager et al.

TRENDS IN MOLECULAR MEDICINE (2015)

Review Cell Biology

The Inflammatory Chemokine CCL5 and Cancer Progression

Donatella Aldinucci et al.

MEDIATORS OF INFLAMMATION (2014)

Article Neurosciences

Estrogen activates matrix metalloproteinases-2 and-9 to increase beta amyloid degradation

Sara Merlo et al.

MOLECULAR AND CELLULAR NEUROSCIENCE (2012)

Review Clinical Neurology

Progressive multiple sclerosis: pathology and pathogenesis

Hans Lassmann et al.

NATURE REVIEWS NEUROLOGY (2012)

Article Pharmacology & Pharmacy

Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis

Chih-Hsin Tang et al.

BIOCHEMICAL PHARMACOLOGY (2010)